UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

Cole, Alice; Denton, Christopher P; (2022) Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD). Current Treatment Options in Rheumatology 10.1007/s40674-022-00196-3. (In press). Green open access

[thumbnail of Denton_Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)_AOP.pdf]
Preview
Text
Denton_Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)_AOP.pdf - Published Version

Download (932kB) | Preview

Abstract

PURPOSE OF REVIEW: Interstitial lung disease (ILD) is the leading cause of mortality in systemic sclerosis, a rare autoimmune disease characterised by fibrosis and vasculopathy. The variety of phenotypes in SSc-ILD have inspired multiple studies aimed at the identification of biomarkers which can provide disease-specific information but due to the complex pathogenesis of SSc-ILD, it has been challenging to validate such markers. We provide a comprehensive update on those most studied along with emerging biomarkers. RECENT FINDINGS: We review the up-to-date findings with regard to the use of well-studied molecular biomarkers in SSc-ILD along with novel biomarkers offering promise as prognostic markers such as IGFBP-2 and IGFBP-7, the adipokine CTRP9, endothelial progenitor cells, and cellular markers such as CD21lo/neg B cells. Expression profiling data is being used in SSc patients to determine genetic and epigenetic clusters which shed further light on mechanisms involved in the pathogenesis of SSc-ILD and are likely to uncover novel biomarkers. SUMMARY: With the exception of autoantibodies, there are no routinely measured biomarkers in SSc-ILD and reliable validation of the many potential biomarkers is lacking. Identifying biomarkers which can offer diagnostic and prognostic certainty may help patients to receive preventative treatment as part of a personalised medicine approach.

Type: Article
Title: Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Open access status: An open access version is available from UCL Discovery
DOI: 10.1007/s40674-022-00196-3
Publisher version: https://doi.org/10.1007/s40674-022-00196-3
Language: English
Additional information: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Keywords: Systemic sclerosis, Interstitial lung disease, Krebs von Lungen-6, Surfactant protein-D and chemokine ligand-18, Biomarkers
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
URI: https://discovery.ucl.ac.uk/id/eprint/10157129
Downloads since deposit
25Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item